Maria Tretiakova
Maria Tretiakova
Anatomic and Clinical pathologist, Associate Professor, University of Washington
Verified email at
Cited by
Cited by
The molecular portraits of breast tumors are conserved across microarray platforms
Z Hu, C Fan, DS Oh, JS Marron, X He, BF Qaqish, C Livasy, LA Carey, ...
BMC genomics 7 (1), 1-12, 2006
Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma
CA Livasy, G Karaca, R Nanda, MS Tretiakova, OI Olopade, DT Moore, ...
Modern pathology 19 (2), 264-271, 2006
Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease
B Meresse, Z Chen, C Ciszewski, M Tretiakova, G Bhagat, TN Krausz, ...
Immunity 21 (3), 357-366, 2004
Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment
H Harlin, Y Meng, AC Peterson, Y Zha, M Tretiakova, C Slingluff, ...
Cancer research 69 (7), 3077-3085, 2009
Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non–small cell lung cancer
PC Ma, R Jagadeeswaran, S Jagadeesh, MS Tretiakova, V Nallasura, ...
Cancer research 65 (4), 1479-1488, 2005
Expression of NOD2 in Paneth cells: a possible link to Crohn’s ileitis
Y Ogura, S Lala, W Xin, E Smith, TA Dowds, FF Chen, E Zimmermann, ...
Gut 52 (11), 1591-1597, 2003
Wnt/β-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome
AI Khramtsov, GF Khramtsova, M Tretiakova, D Huo, OI Olopade, ...
The American journal of pathology 176 (6), 2911-2920, 2010
Loss of E-cadherin promotes ovarian cancer metastasis via α5-integrin, which is a therapeutic target
K Sawada, AK Mitra, AR Radjabi, V Bhaskar, EO Kistner, M Tretiakova, ...
Cancer research 68 (7), 2329-2339, 2008
The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer
IM Kim, T Ackerson, S Ramakrishna, M Tretiakova, IC Wang, TV Kalin, ...
Cancer research 66 (4), 2153-2161, 2006
Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients
L Cheng, CX Pan, XJ Yang, A Lopez‐Beltran, GT MacLennan, H Lin, ...
Cancer 101 (5), 957-962, 2004
Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging
A Oto, A Kayhan, Y Jiang, M Tretiakova, C Yang, T Antic, F Dahi, ...
Radiology 257 (3), 715-723, 2010
Expression and mutational analysis of MET in human solid cancers
PC Ma, MS Tretiakova, AC MacKinnon, N Ramnath, C Johnson, ...
Genes, Chromosomes and Cancer 47 (12), 1025-1037, 2008
Reprogramming of CTLs into natural killer–like cells in celiac disease
B Meresse, SA Curran, C Ciszewski, G Orbelyan, M Setty, G Bhagat, ...
The Journal of experimental medicine 203 (5), 1343-1355, 2006
c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion
K Sawada, AR Radjabi, N Shinomiya, E Kistner, H Kenny, AR Becker, ...
Cancer research 67 (4), 1670-1679, 2007
Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis
A Oto, C Yang, A Kayhan, M Tretiakova, T Antic, C Schmid-Tannwald, ...
American Journal of Roentgenology 197 (6), 1382-1390, 2011
Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation
CR Weber, SC Nalle, M Tretiakova, DT Rubin, JR Turner
Laboratory investigation 88 (10), 1110-1120, 2008
Molecular subclassification of kidney tumors and the discovery of new diagnostic markers
M Takahashi, XJ Yang, J Sugimura, J Backdahl, M Tretiakova, CN Qian, ...
Oncogene 22 (43), 6810-6818, 2003
A molecular classification of papillary renal cell carcinoma
XJ Yang, MH Tan, HL Kim, JA Ditlev, MW Betten, CE Png, EJ Kort, ...
Cancer research 65 (13), 5628-5637, 2005
Expression of α-methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate
XJ Yang, CL Wu, BA Woda, K Dresser, M Tretiakova, GR Fanger, Z Jiang
The American journal of surgical pathology 26 (7), 921-925, 2002
Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma
MH Tan, C Morrison, P Wang, X Yang, CJ Haven, C Zhang, P Zhao, ...
Clinical Cancer Research 10 (19), 6629-6637, 2004
The system can't perform the operation now. Try again later.
Articles 1–20